Neurochemical basis for symptomatic treatment of Alzheimer's disease

Neurochemical basis for symptomatic treatment of Alzheimer's disease

10.1016/j.neuropharm.2010.02.010

Saved in:

Bibliographic Details
Main Authors:	Francis, Paul T, Ramirez, Maria J, Lai, Mitchell K
Other Authors:	DEPT OF PHARMACOLOGY
Format:	Review
Language:	English
Published:	PERGAMON-ELSEVIER SCIENCE LTD 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Neurosciences Pharmacology & Pharmacy Neurosciences & Neurology Alzheimer's disease Neurochemistry Cholinergic Serotonergic Glutamatergic GABAergic 5-HT6 RECEPTOR ANTAGONIST CHOLINE-ACETYLTRANSFERASE ACTIVITY METHYL-D-ASPARTATE MILD COGNITIVE IMPAIRMENT DOUBLE-BLIND SENILE-DEMENTIA BEHAVIORAL SYMPTOMS CEREBRAL-CORTEX MESSENGER-RNA ADRENERGIC-RECEPTORS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/188401
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.1016/j.neuropharm.2010.02.010